Modeling highlights the challenge of maintaining HCV micro-elimination among people who inject drugs
Eric Tatara, Louis Shekhtman, Nicholson Collier, Scott J. Cotler, Mary Ellen Mackesy-Amiti, Basmattee Boodram, Harel Dahari, Marian Major, Jonathan Ozik
doi: https://doi.org/10.1101/2025.07.25.25332212
Eric Tatara
1Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL; Decision and Infrastructure Sciences, Argonne National Laboratory, Argonne, IL, USA
Louis Shekhtman
2Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
3Department of Information Science, Bar-Ilan University, Ramat Gan, Israel
Nicholson Collier
1Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL; Decision and Infrastructure Sciences, Argonne National Laboratory, Argonne, IL, USA
Scott J. Cotler
2Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
Mary Ellen Mackesy-Amiti
4Division of Community Health Sciences, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA
Basmattee Boodram
4Division of Community Health Sciences, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA
Harel Dahari
2Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
Marian Major
5Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
Jonathan Ozik
1Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL; Decision and Infrastructure Sciences, Argonne National Laboratory, Argonne, IL, USA

Data Availability
All data and code used for running experiments, model fitting, and plotting are available on our GitHub repository.
Posted July 29, 2025.
Modeling highlights the challenge of maintaining HCV micro-elimination among people who inject drugs
Eric Tatara, Louis Shekhtman, Nicholson Collier, Scott J. Cotler, Mary Ellen Mackesy-Amiti, Basmattee Boodram, Harel Dahari, Marian Major, Jonathan Ozik
medRxiv 2025.07.25.25332212; doi: https://doi.org/10.1101/2025.07.25.25332212
Modeling highlights the challenge of maintaining HCV micro-elimination among people who inject drugs
Eric Tatara, Louis Shekhtman, Nicholson Collier, Scott J. Cotler, Mary Ellen Mackesy-Amiti, Basmattee Boodram, Harel Dahari, Marian Major, Jonathan Ozik
medRxiv 2025.07.25.25332212; doi: https://doi.org/10.1101/2025.07.25.25332212
Subject Area
Subject Areas
- Addiction Medicine (576)
- Allergy and Immunology (868)
- Anesthesia (306)
- Cardiovascular Medicine (4483)
- Dermatology (385)
- Emergency Medicine (615)
- Epidemiology (15283)
- Forensic Medicine (31)
- Gastroenterology (1134)
- Genetic and Genomic Medicine (6651)
- Geriatric Medicine (671)
- Health Economics (1006)
- Health Informatics (4606)
- Health Policy (1378)
- Hematology (545)
- HIV/AIDS (1276)
- Medical Education (626)
- Medical Ethics (147)
- Nephrology (675)
- Neurology (6699)
- Nursing (346)
- Nutrition (1006)
- Obstetrics and Gynecology (1153)
- Oncology (3370)
- Ophthalmology (989)
- Orthopedics (370)
- Otolaryngology (421)
- Pain Medicine (437)
- Palliative Medicine (131)
- Pathology (670)
- Pediatrics (1704)
- Primary Care Research (717)
- Public and Global Health (9288)
- Radiology and Imaging (2225)
- Respiratory Medicine (1202)
- Rheumatology (598)
- Sports Medicine (536)
- Surgery (722)
- Toxicology (100)
- Transplantation (290)
- Urology (267)




